Top Markets
Coin of the day
Nicox S.A. Nicox S.A.

Nicox S.A.

COX
株式のランク #34243
Nicox S.A. is an ophthalmology enterprise operating both within France and... Nicox S.A. is an ophthalmology enterprise operating both within France and globally, focused on developing therapies to safeguard vision and enhance overall eye health. Its leading investigational drug, NCX 470, an innovative nitric oxide-donating prostaglandin analog designed to decrease intraocular pressure in individuals with open-angle glaucoma or ocular hypertension, is currently undergoing Phase 3 clinical trials. Furthermore, the company is progressing NCX 4251, a specialized fluticasone formulation, through a Phase 2b clinical trial for the management of acute exacerbations of blepharitis, as well as NCX 1728. Nicox also provides VYZULTA, a latanoprostene bunod ophthalmic solution for treating open-angle glaucoma or ocular hypertension, and ZERVIATE, a cetirizine ophthalmic solution to relieve ocular itching related to allergic conjunctivitis. The company, established in 1996, has its main office situated in Valbonne, France.
株価
$0.6379482
最終同期: 2023-05-22
時価総額
$5.98M
変化(1日)
-0.44%
変化(1年)
0.00%
FR
取引 Nicox S.A. (COX)

カテゴリー

Nicox S.A.(COX)の株価履歴
終値の最高値: $0.65 (2023-05-01)

終値の最安値: $102.25 (2000-04-01)
Nicox S.A. の株価履歴(2000 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2023 -48.08%
2022 -59.00%
2021 -42.67%
2020 16.87%
2019 -16.61%
2018 -54.28%
2017 42.86%
2016 -2.69%
2015 -28.86%
2014 -26.67%
2013 9.02%
2012 130.59%
2011 -56.02%
2010 -64.73%
2009 -17.78%
2008 -31.69%
2007 -41.28%
2006 626.06%
2005 -20.50%
2004 16.34%
2003 -70.85%
2002 5.93%
2001 -38.42%
2000 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE